A spinalis izomatrophiát meghatározó survival motoneuron gének kvantitatív analízise

Translated title of the contribution: Quantitative analysis of the genes determining spinal muscular atrophy

Mariann Nagymihály, Ágnes Herczegfalvi, László Tímár, V. Karcagi

Research output: Contribution to journalArticle

Abstract

Spinal muscular atrophy (SMA) is one of the most common autosomal recessive diseases, affecting approximately one in 10.000 live births and with a carrier frequency of approximately one in 35. The disease is caused by a deficiency of the ubiquitous protein survival of motor neuron (SMN), which is encoded by the SMN1 and SMN2 genes. Due to a single nucleotide polymorphism in exon 7, SMN2 produces less full-length transcript than SMN1 and cannot prevent neuronal cell death at physiologic gene dosages. On the other hand, the copy number of SMN2 affects the amount of SMN protein produced and the severity of the SMA phenotype. SMN gene dosage analysis can determine the copy number of SMN1 to detect carriers and patients heterozygous for the absence of SMN1 exon 7. This study provides copy number estimation of SMN1 gene by real-time PCR technique in 56 SMA type I., II., III. patients, 159 parents and healthy relatives and in 152 undefined SMA patients. Among the family members, 91 carriers have been detected and in 56 patients homozygous deletion of SMN1 exon 7 has been confirmed. Moreover, in 12 patients compound heterozygosity of SMN1 exon 7 mutation has been detected, thus providing the possible diagnosis of SMA. In 94 patients, copy number of SMN2 has also been evaluated and a good correlation has been found with the phenotype of the disease. Due to the genetic complexity and the high carrier frequency, accurate risk assessment and genetic counselling are particularly important for the families. These new results provide improvement of the diagnostic service in SMA in Hungary with focus on proper genetic counselling and possible enrolment of the patients in future therapeutic interventions.

Original languageHungarian
Pages (from-to)390-397
Number of pages8
JournalIdeggyógyászati szemle
Volume62
Issue number11-12
Publication statusPublished - Nov 30 2009

Fingerprint

Spinal Muscular Atrophy
Exons
Motor Neurons
Genes
Gene Dosage
Genetic Counseling
Spinal Muscular Atrophies of Childhood
Diagnostic Services
Phenotype
Protein Deficiency
Hungary
Live Birth
Single Nucleotide Polymorphism
Real-Time Polymerase Chain Reaction
Cell Death
Parents
Mutation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

A spinalis izomatrophiát meghatározó survival motoneuron gének kvantitatív analízise. / Nagymihály, Mariann; Herczegfalvi, Ágnes; Tímár, László; Karcagi, V.

In: Ideggyógyászati szemle, Vol. 62, No. 11-12, 30.11.2009, p. 390-397.

Research output: Contribution to journalArticle

Nagymihály, M, Herczegfalvi, Á, Tímár, L & Karcagi, V 2009, 'A spinalis izomatrophiát meghatározó survival motoneuron gének kvantitatív analízise', Ideggyógyászati szemle, vol. 62, no. 11-12, pp. 390-397.
Nagymihály, Mariann ; Herczegfalvi, Ágnes ; Tímár, László ; Karcagi, V. / A spinalis izomatrophiát meghatározó survival motoneuron gének kvantitatív analízise. In: Ideggyógyászati szemle. 2009 ; Vol. 62, No. 11-12. pp. 390-397.
@article{e8d6c4d4a60844519a06181fdefc3bd4,
title = "A spinalis izomatrophi{\'a}t meghat{\'a}roz{\'o} survival motoneuron g{\'e}nek kvantitat{\'i}v anal{\'i}zise",
abstract = "Spinal muscular atrophy (SMA) is one of the most common autosomal recessive diseases, affecting approximately one in 10.000 live births and with a carrier frequency of approximately one in 35. The disease is caused by a deficiency of the ubiquitous protein survival of motor neuron (SMN), which is encoded by the SMN1 and SMN2 genes. Due to a single nucleotide polymorphism in exon 7, SMN2 produces less full-length transcript than SMN1 and cannot prevent neuronal cell death at physiologic gene dosages. On the other hand, the copy number of SMN2 affects the amount of SMN protein produced and the severity of the SMA phenotype. SMN gene dosage analysis can determine the copy number of SMN1 to detect carriers and patients heterozygous for the absence of SMN1 exon 7. This study provides copy number estimation of SMN1 gene by real-time PCR technique in 56 SMA type I., II., III. patients, 159 parents and healthy relatives and in 152 undefined SMA patients. Among the family members, 91 carriers have been detected and in 56 patients homozygous deletion of SMN1 exon 7 has been confirmed. Moreover, in 12 patients compound heterozygosity of SMN1 exon 7 mutation has been detected, thus providing the possible diagnosis of SMA. In 94 patients, copy number of SMN2 has also been evaluated and a good correlation has been found with the phenotype of the disease. Due to the genetic complexity and the high carrier frequency, accurate risk assessment and genetic counselling are particularly important for the families. These new results provide improvement of the diagnostic service in SMA in Hungary with focus on proper genetic counselling and possible enrolment of the patients in future therapeutic interventions.",
keywords = "Copy number analysis of SMN1 and SMN2 genes, Real-time PCR, Spinal muscular atrophy",
author = "Mariann Nagymih{\'a}ly and {\'A}gnes Herczegfalvi and L{\'a}szl{\'o} T{\'i}m{\'a}r and V. Karcagi",
year = "2009",
month = "11",
day = "30",
language = "Hungarian",
volume = "62",
pages = "390--397",
journal = "Ideggyogyaszati Szemle",
issn = "0019-1442",
publisher = "Ifjusagi Lap-es Konyvkiado Vallalat",
number = "11-12",

}

TY - JOUR

T1 - A spinalis izomatrophiát meghatározó survival motoneuron gének kvantitatív analízise

AU - Nagymihály, Mariann

AU - Herczegfalvi, Ágnes

AU - Tímár, László

AU - Karcagi, V.

PY - 2009/11/30

Y1 - 2009/11/30

N2 - Spinal muscular atrophy (SMA) is one of the most common autosomal recessive diseases, affecting approximately one in 10.000 live births and with a carrier frequency of approximately one in 35. The disease is caused by a deficiency of the ubiquitous protein survival of motor neuron (SMN), which is encoded by the SMN1 and SMN2 genes. Due to a single nucleotide polymorphism in exon 7, SMN2 produces less full-length transcript than SMN1 and cannot prevent neuronal cell death at physiologic gene dosages. On the other hand, the copy number of SMN2 affects the amount of SMN protein produced and the severity of the SMA phenotype. SMN gene dosage analysis can determine the copy number of SMN1 to detect carriers and patients heterozygous for the absence of SMN1 exon 7. This study provides copy number estimation of SMN1 gene by real-time PCR technique in 56 SMA type I., II., III. patients, 159 parents and healthy relatives and in 152 undefined SMA patients. Among the family members, 91 carriers have been detected and in 56 patients homozygous deletion of SMN1 exon 7 has been confirmed. Moreover, in 12 patients compound heterozygosity of SMN1 exon 7 mutation has been detected, thus providing the possible diagnosis of SMA. In 94 patients, copy number of SMN2 has also been evaluated and a good correlation has been found with the phenotype of the disease. Due to the genetic complexity and the high carrier frequency, accurate risk assessment and genetic counselling are particularly important for the families. These new results provide improvement of the diagnostic service in SMA in Hungary with focus on proper genetic counselling and possible enrolment of the patients in future therapeutic interventions.

AB - Spinal muscular atrophy (SMA) is one of the most common autosomal recessive diseases, affecting approximately one in 10.000 live births and with a carrier frequency of approximately one in 35. The disease is caused by a deficiency of the ubiquitous protein survival of motor neuron (SMN), which is encoded by the SMN1 and SMN2 genes. Due to a single nucleotide polymorphism in exon 7, SMN2 produces less full-length transcript than SMN1 and cannot prevent neuronal cell death at physiologic gene dosages. On the other hand, the copy number of SMN2 affects the amount of SMN protein produced and the severity of the SMA phenotype. SMN gene dosage analysis can determine the copy number of SMN1 to detect carriers and patients heterozygous for the absence of SMN1 exon 7. This study provides copy number estimation of SMN1 gene by real-time PCR technique in 56 SMA type I., II., III. patients, 159 parents and healthy relatives and in 152 undefined SMA patients. Among the family members, 91 carriers have been detected and in 56 patients homozygous deletion of SMN1 exon 7 has been confirmed. Moreover, in 12 patients compound heterozygosity of SMN1 exon 7 mutation has been detected, thus providing the possible diagnosis of SMA. In 94 patients, copy number of SMN2 has also been evaluated and a good correlation has been found with the phenotype of the disease. Due to the genetic complexity and the high carrier frequency, accurate risk assessment and genetic counselling are particularly important for the families. These new results provide improvement of the diagnostic service in SMA in Hungary with focus on proper genetic counselling and possible enrolment of the patients in future therapeutic interventions.

KW - Copy number analysis of SMN1 and SMN2 genes

KW - Real-time PCR

KW - Spinal muscular atrophy

UR - http://www.scopus.com/inward/record.url?scp=76549105252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76549105252&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 390

EP - 397

JO - Ideggyogyaszati Szemle

JF - Ideggyogyaszati Szemle

SN - 0019-1442

IS - 11-12

ER -